METTL3 and endometrium neoplasm: Liu et al. found that approximately 70% of endometrial tumors exhibit reduced m6A methylation, which may be owing to mutations in METTL14 or reduced expression of METTL3 (another component of the methylation transferase complex), and that these changes lead to a possible increase in endometrial tumorigenicity33.